Predicting heart disease in patients with chronic kidney disease in Poland
Official title: Cardiovascular Disease in Patients With Chronic Kidney Disease: Polish Kidney- Heart Project
Run by Medical University of Silesia · NCT06083168 · Data updated 2026-11-12
This study is trying to see if collecting health data from people with chronic kidney disease in Poland can help predict heart problems and other related issues over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 6000 (estimated) |
| Sponsor | Medical University of Silesia Academic / other |
| Locations | 2 sites (Olsztyn and 1 other locations) |
| Status | Recruiting |
| Started | December 1, 2023 |
| Main results expected | November 30, 2033 |
| Study ends | January 31, 2036 |
| Registry record updated | May 2, 2024 |
| Trial ID | NCT06083168 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients diagnosed with chronic kidney disease, characterized by an eGFR of less than 60 ml/min/1.73 m2 or elevated urine albumin creatinine ratio.
✕Probably not a fit
Patients who are terminally ill with cancer or unable to provide informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational longitudinal study aims to collect demographic, laboratory, and clinical data from patients with chronic kidney disease (CKD) in Poland to predict the onset of cardiovascular disease and related events. The study will utilize machine learning and artificial intelligence to analyze the data collected from two academic centers over a period of 10 years. Patients will receive annual follow-ups via telephone and on-site health checks to monitor their health outcomes, including cardiovascular events and progression of kidney disease. A subgroup analysis will focus on patients with diabetes and CKD.
Why it matters
Potential benefit: If successful, this study could lead to improved prediction and management of cardiovascular risks in patients with chronic kidney disease.
How similar studies have gone: Other studies have shown success in using machine learning approaches to predict cardiovascular events in patients with chronic kidney disease, making this approach promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * CKD defined as estimated glomerular filtration rate (eGFR) \< 60ml/min/1.73 m2 and/or urine albumin creatinine ratio ( UACR) \> 30 mg/g lasting at least 3 months * CKD regardless of eGFR/albuminuria when documented otherwise (by means of imaging, renal biopsy result, genetic background, etc) Exclusion Criteria: * Death during hospital stay * Terminal stage of cancer * Lack of an informed consent
Where it's running
-
Wojewódzki Szpital Specjalistyczny w Olsztynie
Olsztyn, Poland Recruiting -
Samodzielny Publiczny Szpital Kliniczny Nr 1 im. prof. Stanisława Szyszko Śląskiego Uniwersytetu Medycznego w Katowicach
Zabrze, Poland Recruiting
Study contacts
- Principal investigator: Katarzyna Nabrdalik, assoc. Prof — Medical University of Silesia
- Study coordinator: Katarzyna Nabrdalik, assoc. Prof
- Email: knabrdalik@sum.edu.pl
- Phone: 0048323704438
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Optimised Cardio-Renal Care for CKD and heart disease
This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.
-
Home-based cardiovascular health screening for people turning 50, 55, 60, 65, 70 or 75 in Uppsala
This trial tests whether giving people a home blood pressure monitor, a dried blood spot kit, and a questionnaire can find more cardiovascular risk factors than usual care.
-
Home exercise program for patients with advanced chronic kidney disease
This study is testing whether a simple home exercise program can help people with advanced chronic kidney disease feel better and improve their overall health.
-
Investigating nutritional and environmental factors in elderly health
This study is trying to find out how nutrition and the environment affect the health of older people living in Nanshan to help prevent diseases like high blood pressure and diabetes.
-
Observational look at how Kremezin works in adults with advanced chronic kidney disease
This study tests whether Kremezin helps adults with advanced kidney disease when used as part of routine care, by tracking safety and kidney function over up to 48 weeks.
-
Kidney and Heart Health in Adults with Type 2 Diabetes and CKD Treated with Semaglutide in China
This study tests whether semaglutide injections help kidney and heart health in adults with type 2 diabetes and chronic kidney disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.